The recent run of good fortune for vaccine maker Novavax (NASDAQ:NVAX continues. Following the major licensing deal with ...
Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in Novavax almost doubled ...
Sanofi on Friday said it had reached a deal worth up to $1.2 billion to sell Novavax’s Covid shot as well as to try to ...
Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in ...
Novavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to $1.4 billion with Sanofi ...
GXO Opens up New Distribution Hub for Conair <li /> Sinclair Ponders Unloading Stations <li /> AMC Plunges on Q1 Figures <li ...
Novavax shares jumped 50% on Monday following its recent licensing deal with Sanofi, as meme stocks are making a 2021-style ...
Novavax (NVAX) shares are skyrocketing after the company announced a $1.2 billion deal with French drugmaker Sanofi (SNY). B.
Novavax agreed to license its vaccine technology to French drugmaker Sanofi to co-commercialize its COVID-19 vaccine, and also develop other vaccines.
On today's episode of The Morning Brief, Hosts Seana Smith and Brad Smith break down some of the biggest news affecting the ...